一
国际海关政策动态


01 

美国海关现代化法案成形


美国近30年来首部海关现代化法案正在成形,美国国会近来正就草案征询商界意见(截止到11月20日)。美国海关(CBP)称该立法融合了现代程序和技术,将有助于推进CBP的“21世纪海关框架”,更好地保障国家和经济安全,提高数据完整性,利用新的机遇,并实现长期的转变。该草案在贸易数据、申报、记录保存、处罚、知识产权、没收、逃避反倾销/反补贴税以及对“黑名单”人员的处置等方面都做了调整,广泛扩展了CBP在数据获取和执法上的权限,同时加强了执法力度。
详情链接

0 1
点评

这项题为《2021年海关现代化法案》的草案旨在更新1993年的《海关现代化法案》,疑似《海关现代化法案》2.0版。但其内容并未聚焦贸易界对“现代化”的全面期许,具有减轻贸易界负担和成本的新措施似乎寥寥无几,其着重点明显是放在通过修订相关法律来扩大和加强海关的执法权上,并未承载“现代”的完整内涵。对此贸易界将如何反应以及该法案制订的走向如何,值得密切关注。


02 

USTR延长中国医护产品的301关税豁免期


美国贸易代表办公室(USTR)将99项用于抗击新冠的中国医护产品的301关税豁免期从11月14日延至11月30日。其中的81项将会继续延期至2022年5月31日,其余18项则不再延期。

对于不再延期的产品,USTR在12月1日前会开放公众评议渠道,接收关于这部分中国产品是否应该继续延期,以及延期多长的公众意见。是否继续延期的决定将会追溯至2021年10月12日。

详情链接


03 

加拿大海关首次没收“强迫劳动”产品



2021年11月15日,加拿大媒体报道了一则进口货物因被认定为“强迫劳动”产品而遭到没收的消息。据加拿大海关(CBSA)称,海关没收了该批自中国输往魁北克的女装和童装,进口和出口商的具体信息尚未公开。此次报道为加拿大反强迫劳动执法案件的首次公开报道。

加拿大税则明确禁止进口“全部或部分使用强迫劳动采集或制造生产的产品”。CBSA政策备忘录D9-1-6表示,CBSA可能会利用ESDC-Labour(加拿大雇佣和社会发展部劳动力项目)的调查信息来查找和扣留相关货物,此次执法便是行动开始的明证。媒体也越来越多地聚焦这个问题,对政府的执法起到了推波助澜的作用。进口商审查其供应链和实行供应链风险评估愈加重要和必要。

详情链接

二
国际组织贸易便利化协定(TFA)动态


01 

TFA签订最新进展


TFA核准成员数为154,占比率为93.9%,全部WTO成员执行TFA承诺比率为70.4%。(自2021年6月30日起无变化)
详情链接

02 

APEC通过 《2021年APEC领导人宣言》


亚太经合组织(APEC)第二十八次领导人非正式会议通过了《2021年APEC领导人宣言》。宣言指出APEC将加快落实《互联网和数字经济路线图》,鼓励新技术运用,努力构建开放、公平、包容的数字营商环境。贸易是全体人民发展和繁荣的支柱,APEC将推进区域经济一体化,推进亚太自由贸易区建设,为实现全面高质量的区域贸易协定作出贡献。

详情链接
03 

UNECE相关工具帮助落实七国集团数字贸易原则


由欧洲经委会(UNECE)负责的联合国贸易便利化和电子商务中心(UN/CEFACT)是贸易便利化相关建议和电子商务标准的协调中心。UN/CEFACT的很多工具和标准提供了互操作性,能够促进运输方式、部门、公司、机构和国家之间的数字信息交换。该体系将用于协助落实G7数字贸易原则。此前,七国集团 (G7)贸易部长就规制数字贸易和数据跨境的各项原则达成共识,同意推动贸易相关文件的数字化,以确保共同标准,并简化利益相关者与边境机构的业务流程。

详情链接


04 

WCO强调推进发展eATA和eCPD单证系统


世界海关组织(WCO)伊斯坦布尔公约管理委员会与《ATA公约》缔约方会举行联席会议,强调将 ATA单证(暂时进境货物单证册)及CPD单证(运输工具的暂时进境单证册)数字化的重要性。eATA和eCPD更简单、更安全,能为海关及私营机构的利益相关者提供更便捷及更有效的暂准进口程序。国际商会开发的eATA系统将从2023年开始运行。会议还分享了俄罗斯联邦和欧盟的相关经验。

详情链接

三
报告及评论摘要


01 

2021世界贸易报告探讨“全球贸易体制中的脆弱与强韧”


11月16日,WTO《世界贸易报告》2021版刊发旗舰内容,探讨在日益频发且激烈的自然和人为灾难面前,为何连接紧密的全球贸易体制显示出脆弱又强韧的特性?这个体制如何能帮助各国面对灾难冲击时更具经济韧性?未来应该做些什么来使应对冲击时有备无患?报告主要传递了以下3个信息:

1.  当今全球经济的高度联结使其在面对自然和人为灾难冲击时更为脆弱,但同时也更加强韧;

2.  通过放松贸易一体化的做法(如回迁国内产业,提升自给能力)来增加经济韧性的政策通常会产生反效果,会显著降低经济韧性;

3.  加强经济韧性要求更多全球(区域化以及多边)合作。

详情链接

02 

出口大跌导致美国贸易赤字创新高


美国货物与服务贸易赤字9月两次创新高,飙升11.1%,达809亿美元。根据美国商务部统计数据,9月进口微升0.6%至2885亿美元,出口跌3%达2076亿美元。

出口大幅下跌导致贸易赤字走高,其中货物贸易出口下跌达4.7%,是导致赤字飙高的主因;服务贸易则与货物贸易逆向行进,出口增加,进口减少。9月美国贸易赤字同比上升33.1%。

贸易赤字来源国中,总额最高的仍然是中国,达到315亿美元;上升率最高的是墨西哥,为33.3%;对日本、欧盟、印度和沙特则处于赤字下降状态。

详情链接

03 

GATF报告《作为信任催化剂的贸易便利化改革》


全球贸易便利化联盟(GATF)为了解公共部门和私营部门之间的信任程度,针对信任对国际贸易的影响进行了开创性的研究。研究发现,通过一系列简单的策略,如建立对话空间、共同目标、提升领导能力和受尊敬的第三方等,可以在很短的时间内建立和改善私营部门和公共部门之间的关系。有研究考察了哥伦比亚汽车行业和海关之间实施合作措施对双方关系的影响。67%的私营和公共部门利益相关者表示,他们对彼此的信任有所增长。受访者表示,沟通状况有所改善,双方对彼此的需求和利益有了更好的把握。

详情链接


四
他山之石


01 

韩国海关的电子商务监管


韩国海关重点使用三种类型的技术加强电子商务监管能力:

1.  区块链:在区块链项目试点中,所有各方(卖方、快递承运人和报关行等)都将他们的信息或链上数据直接实时发送给海关,缺点是成本较高且遇到大容量数据传输问题;

2.  人工智能:韩国海关开发自动检测工具增强图像处理能力,通过将扫描仪接收到的数据与货物舱单或海关申报单中的数据进行比较来确定单货是否匹配。在2017年开展了概念验证(POC)项目研究,通过人工智能建立起一个大规模的参考数据库,构建自动识别危险的算法,以识别高风险商品,并修改或创建新的算法;

3.  大数据:韩国海关从2017年开始利用大数据。大数据应用加强了海关稽查能力,更有效地打击税务欺诈,提高了进出口数据的可比性。2020年,韩国海关建立全国海关的大数据系统,成立了专门的团队来开发和操作分析工具。

韩国海关从上述工作中总结出几点结论:一是使用技术的关键是访问数据;其次,技术专家与关务专家的合作才能确保技术方案完备;最后,整个海关层面的创新意识以及国际合作不可或缺。

来源:WCO杂志第96期(详情链接)


五
国际海关研究


01 

量化海关、贸易商和港口对货物时间延误的相对影响程度


《世界海关期刊》上刊登的一项研究对相关文献综述和研究方法做了介绍,包括选取港口情况、港口交通情况和处理船舶时间等。研究通过对东非主要港口进口和过境货物的海关流程和港口作业流程进行分析,通过测量各个操作端口的操作时间,包括收集同一时期和同一货物的海关和港口业务的数据,比较了海关放行日期和港口相关发票付款日期的先后。研究还探讨了从这些港口通关的货物出现长时间延误的原因,确定并量化了海关、贸易商和港口作业对货物时间延误的影响程度。研究发现,海关流程是进口货物延误的主要原因,而码头操作流程是运输延误的主要原因,然而,贸易商的反应时间也很大程度上导致了延误。此外,有些情况,如邻国的贸易商无法直接进入港口的电子发票系统,也会加剧延误。进行原因分析后作者提出了建议:实施电子单一窗口系统,并实施海关风险管理以减少货物查验。

来源:世界海关期刊第15期2021年3月(详情链接)


相关附件

附件内容预览
Billing Code 3290-F2 OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE Notice of Product Exclusion Extensions: China’s Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation AGENCY: Office of the United States Trade Representative (USTR). ACTION: Notice. SUMMARY: In prior notices, the U.S. Trade Representative modified the action in the Section 301 investigation of China’s acts, policies, and practices related to technology transfer, intellectual property, and innovation by excluding from additional duties certain medical-care products needed to address the COVID-19 pandemic. The 99 exclusions for medical care products to address COVID-19 were published on December 29, 2020, and are scheduled to expire on November 14, 2021. On August 27, 2021, USTR requested comments on whether to extend the COVID exclusions. This notice announces the U.S. Trade Representative’s determination to provide a 16-day transition period for all COVID exclusions (through November 30, 2021), and to extend 81 of the COVID exclusions for an additional 6 months. DATES: To provide a transition period, this notice extends the 99 exclusions scheduled to expire on November 14, 2021, through November 30, 2021. Those exclusions receiving further extensions will expire six months after November 30, 20201, on May 31, 2022. U.S. Customs and Border Protection will issue instructions on entry guidance and implementation. FOR FURTHER INFORMATION CONTACT: For general questions about this notice, contact Associate General Counsel Philip Butler or Assistant General Counsel 1 Rachel Komito at (202) 395-5725. For specific questions on customs classification or implementation of the product exclusions, contact traderemedy@cbp.dhs.gov. SUPPLEMENTARY INFORMATION: A. Background In the course of this investigation the U.S. Trade Representative imposed additional duties on products of China in four tranches. See 83 FR 28719 (June 20, 2018); 83 FR 40823 (August 16, 2018); 83 FR 47974 (September 21, 2018), as modified by 83 FR 49153 (September 28, 2018); and 84 FR 43304 (August 20, 2019), as modified by 84 FR 69447 (December 18, 2019) and 85 FR 3741 (January 22, 2020). For each tranche, the U.S. Trade Representative established a process by which U.S. stakeholders could request the exclusion of particular products subject to the action. The U.S. Trade Representative later established a process by which U.S. stakeholders could request the extension of particular exclusions. Additionally, on March 25, 2020, the U.S. Trade Representative requested public comments on possible further modifications to remove Section 301 duties from medical-care products to address the COVID-19 pandemic. 85 FR 16987. On December 29, 2020, USTR announced the extension of 80 product exclusions on medical-care and/or COVID response products; further modifications in the form of 19 product exclusions to remove Section 301 duties from additional medical-care and/or COVID response products; and that USTR might consider further extensions and/or modifications as appropriate. See 85 FR 85831 (the December 29 notice). On March 10, 2021, USTR announced the extension of these 99 exclusions until September 30, 2021, and that USTR might consider further extensions and/or modifications as appropriate. 86 2 FR 13785. On August 27, 2021, USTR published a notice requesting public comments on whether any of these exclusions should be further extended for up to six months. 86 FR 48280 (the August 27 notice). The August 27 notice stated that USTR would evaluate each exclusion on a case-by-case basis and the evaluation would examine whether the exclusion remains appropriate in light of recent developments including the spread of the Delta variant in the United States and increased domestic production of certain products, and taking account of the overall impact of these exclusions on the goal of obtaining the elimination of China’s acts, policies, and practices covered in this Section 301 investigation. On September 29, 2021, USTR announced the interim extension of these 99 exclusions through November 14, 2021, in order to provide time to review public comments submitted in response to the August 27 notice. 86 FR 54011. B. Determination to Extend Certain Exclusions Based on evaluation of the factors set out in in the August 27 notice, and pursuant to sections 301(b), 301(c), and 307(a) of the Trade Act of 1974, as amended, the U.S. Trade Representative has determined to extend certain product exclusions described in the December 29 notice for six months past the expiry of the remaining exclusions (until May 31, 2022), as set out in the annexes to this notice. The U.S. Trade Representative’s determination considers public comments submitted in response to the August 27 notice, and the advice of advisory committees, the interagency Section 301 Committee, and the White House COVID-19 Response Team. 3 To provide a transition period for the expiring exclusions, the U.S. Trade Representative has determined to extend all 99 product exclusions described in the December 29 notice through November 30, 2021. The exclusion extensions are available for any product that meets the description in the product exclusion. Further, the scope of each exclusion and modification is governed by the scope of the ten-digit Harmonized Tariff Schedule of the United States (HTSUS) subheadings and product descriptions in the annexes to this notice. U.S. Customs and Border Protection will issue instructions on entry guidance and implementation. The U.S. Trade Representative may continue to consider further extensions and/or additional modifications as appropriate. Greta Peisch General Counsel Office of the United States Trade Representative. 4 Annex for COVID Extensions Annex A Effective with respect to goods entered for consumption, or withdrawn from warehouse for consumption, on or after 12:01 a.m. eastern daylight time on November 15, 2021, and before 11:59 p.m. eastern daylight time on November 30, 2021, each of the article descriptions of headings 9903.88.62, 9903.88.63, 9903.88.64 and 9903.88.65 of the Harmonized Tariff Schedule of the United States are modified by deleting “November 14, 2021,” and by inserting “November 30, 2021,” in lieu thereof. Annex B A. Effective with respect to goods entered for consumption, or withdrawn from warehouse for consumption, on or after 12:01 a.m. eastern daylight time on December 1, 2021 and before 11:59 p.m. eastern daylight time on May 31, 2022, subchapter III of chapter 99 of the Harmonized Tariff Schedule of the United States (HTSUS) is modified: 1. by inserting the following new heading 9903.88.66 in numerical sequence, with the material in the new heading inserted in the columns of the HTSUS labeled “Heading/Subheading”, “Article Description”, and “Rates of Duty 1-General”, respectively: Rates of Duty Heading/ Article Description 1 2 Subheading General Special “9903.88.66 Effective with respect to entries on or after The duty December 1, 2021, and before June 1, 2022, provided in articles the product of China, as provided for in the U.S. note 20(sss) to this subchapter, each applicable covered by an exclusion granted by the U.S. subheading” Trade Representative . . . . . 2. by inserting the following new U.S. note 20(sss) to subchapter III of chapter 99 in numerical sequence: “(sss) (i) The U.S. Trade Representative determined to establish a process by which particular products classified in heading 9903.88.01 and provided for in U.S. notes 20(a) and 20(b) to this subchapter could be excluded from the additional duties imposed by heading 9903.88.01. See 83 Fed. Reg. 40823 (August 16, 2018) and 83 Fed. Reg. 47326 (September 18, 2018). Pursuant to the product exclusion process, the U.S. Trade Representative has determined that, as provided in heading 9903.88.66, the additional duties provided for in heading 9903.88.01 shall not apply to the following particular products, which are provided for in the enumerated statistical reporting numbers: 5 (1) Disposable plastic filters of a kind suitable for filtering and dehumidifying a patient's breath in a medical device such as a gas analyzer (described in statistical reporting number 8421.39.8090) (2) S-band and X-band linear accelerators designed for use in radiation surgery or radiation therapy equipment (described in statistical reporting number 8543.10.0000) (3) Disposable electrocardiograph (ECG) electrodes (described in statistical reporting number 9018.11.9000) (4) Ultrasonic scanning apparatus, each having dimensions not exceeding 122 cm by 77 cm by 127 cm, whether or not presented with transducer (described in statistical reporting number 9018.12.0000) (5) Blood pressure monitors suitable for use by medical professionals (described in statistical reporting number 9018.19.9530) (6) Digital peak flow meters suitable for use by medical professionals (described in statistical reporting number 9018.19.9550) (7) Fingertip pulse oximeters suitable for use by medical professionals (described in statistical reporting number 9018.19.9550) (8) Bismuth germanate crystals with set dimensional and surface finish requirements and used as a detection element in Positron Emission Tomography (PET) detectors (described in statistical reporting number 9018.19.9560) (9) Magnetic resonance imaging ("MRI") patient enclosure devices, each incorporating radio frequency and gradient coils (described in statistical reporting number 9018.19.9560) (10) Parts and accessories of capnography monitors (described in statistical reporting number 9018.19.9560) (11) Disposable surface electrodes for Intra-operative neuromonitoring (“IONM”) systems, each composed of a surface electrode pad, an insulated wire, and a standard DIN 42802 connector (described in statistical reporting number 9018.19.9560) (12) Otoscopes (described in statistical reporting number 9018.90.2000) (13) Anesthesia masks (described in statistical reporting number 9018.90.3000) (14) Anesthetic instruments and appliances suitable for use in medical or surgical sciences, and parts and accessories of the foregoing (described in statistical reporting number 9018.90.3000) (15) Electrosurgical cautery pencils with electrical connectors (described in statistical reporting number 9018.90.6000) (16) Printed circuit board assemblies designed for use in displaying operational performance of medical infusion equipment (described in statistical reporting number 9018.90.7580) (17) Combined positron emission tomography/computed tomography (PET/CT) scanners which utilize multiple PET gantries (frames) on a common base (described in statistical reporting number 9022.12.0000) (18) X-ray tables (described in statistical reporting number 9022.90.2500) (19) X-ray tube housings and parts thereof (described in statistical reporting number 9022.90.4000) 6 (20) Multi-leaf collimators of radiotherapy systems based on the use of X-ray (described in statistical reporting number 9022.90.6000) (21) Parts and accessories, of metal, for mobile X-ray apparatus (described in statistical reporting number 9022.90.6000) (22) Vertical stands specially designed to support, contain or adjust the movement of X-ray digital detectors, or the X-ray tube and collimator in complete X-ray diagnostic systems (described in statistical reporting number 9022.90.6000) (23) Thermoplastic masks of polycaprolactone for the use of immobilizing patients, during the use of alpha, beta or gamma radiations, for radiography or radiotherapy (described in statistical reporting number 9022.90.9500) (24) Inoculator sets of plastics, each consisting of a plate with multiple wells, a display tray, and a lid; when assembled, the set measuring 105 mm or more but not exceeding 108 mm in width, 138 mm or more but not exceeding 140 mm in depth, and 6.5 mm or less in thickness (described in statistical reporting number 9027.90.5650) (ii) The U.S. Trade Representative determined to establish a process by which particular products classified in heading 9903.88.02 and provided for in U.S. notes 20(c) and 20(d) to this subchapter could be excluded from the additional duties imposed by heading 9903.88.02. See 83 Fed. Reg. 40823 (August 16, 2018) and 83 Fed. Reg. 47326 (September 18, 2018). Pursuant to the product exclusion process, the U.S. Trade Representative has determined that, as provided in heading 9903.88.66, the additional duties provided for in heading 9903.88.02 shall not apply to the following particular products, which are provided for in the enumerated statistical reporting numbers: (1) 9025.19.8010 (2) 9025.19.8020 (3) 9025.19.8060 (4) 9025.19.8085 (5) Molded acrylonitrile-butadiene-styrene (ABS) tubes, of a kind used to effect the sterile transfer of fluid from a bag or vial to another container, each tube measuring 7.5 cm or more but not exceeding 23 cm in length, with an inner diameter of less than 0.65 cm and an outer diameter of less than 9 cm, one end having been angle-cut to form a spike, and having an integrated flange, less than 3 cm in diameter (splash guard) near the spike end and removable polyethylene caps on each end, put up in sterile packing (described in statistical reporting number 3917.29.0090) (6) Rectangular sheets of high-density or low-density polyethylene, 111.75 cm to 215.9 cm in width, and 152.4 cm to 304.8 cm in length, with a sticker attached to mark the center of each sheet, of a kind used in hospital or surgery center operating rooms (described in statistical reporting number 3920.10.0000) (7) Sheets and strips consisting of both cross-linked polyethylene and ethylene vinyl acetate, of a width greater than 1 m but not greater than 1.5 m, and a length greater than 1.75 m but not greater than 2.6 m (described in statistical reporting number 3921.19.0000) 7 (8) Polyethylene sheet and film laminated with spunbond-spunbond-spunbond nonwoven polypropylene fabric, measuring 1.12 m or more but not over 1.52 m in width and 1.93 m or more but not over 2.29 m in length, and weighing 55 g/m² or more but not exceeding 88 g/m² (described in statistical reporting number 3921.90.1500) (9) Dispensers of hand-cleaning or hand-sanitizing solutions, whether employing a manual pump or a proximity-detecting battery-operated pump, each article weighing not more than 3 kg (described in statistical reporting number 8424.89.9000) (iii) The U.S. Trade Representative determined to establish a process by which particular products classified in heading 9903.88.03 and provided for in U.S. notes 20(e) and 20(f) to this subchapter could be excluded from the additional duties imposed by heading 9903.88.03, and by which particular products classified in heading 9903.88.04 and provided for in U.S. note 20(g) to this subchapter could be excluded from the additional duties imposed by heading 9903.88.04. See 83 Fed. Reg. 47974 (September 21, 2018) and 84 Fed. Reg. 29576 (June 24, 2019). Pursuant to the product exclusion process, the U.S. Trade Representative has determined that, as provided in heading 9903.88.66, the additional duties provided for in heading 9903.88.03 or in heading 9903.88.04 shall not apply to the following particular products, which are provided for in the enumerated statistical reporting numbers: (1) 3808.94.1000 (2) 3808.94.5010 (3) 3923.21.0095 (4) 3926.20.9050 (5) 4819.50.4060 (6) 5603.12.0090 (7) 5603.14.9090 (8) 5603.92.0090 (9) 5603.93.0090 (10) 6505.00.8015 (11) 8424.90.9080 (12) Sodium metal (CAS No. 7440-23-5), in bulk solid form (described in statistical reporting number 2805.11.0000) (13) Disposable cloths of nonwoven textile materials impregnated, coated or covered with organic surface-active preparations for washing the skin, put up for retail sale (described in statistical reporting number 3401.30.5000) (14) Mixtures containing 2-(dimethylamino)ethanol (CAS No. 108-01-0) (described in statistical reporting number 3824.99.9297) (15) Silicon monoxide (SiO) (CAS No. 10097-28-6) in powder form (described in statistical reporting number 3824.99.9297) (16) Flexible gas sampling tubes, pipes and hoses, of polyvinyl chloride, with lock connectors at each end (described in statistical reporting number 3917.33.0000) 8 (17) Flexible oxygen tubes, pipes and hoses presented with integrated molded connectors, of polyvinyl chloride (described in statistical reporting number 3917.33.0000) (18) Container units of plastics, each comprising a tub and lid therefore, configured or fitted for the conveyance, packing, or dispensing of wet wipes (described in statistical reporting number 3923.10.9000) (19) Sacks and bags of polymers of ethylene, reclosable, qualifying as Class 1 medical devices by the U.S. Food and Drug Administration under product code NNI (described in statistical reporting number 3923.21.0030) (20) Injection molded polypropylene plastic caps or lids each weighing not over 24 grams designed for dispensing wet wipes (described in statistical reporting number 3923.50.0000) (21) Hand pumps (other than for fuel or lubricants, not fitted or designed to be fitted with a metering device), each used to dispense a metered quantity of liquid soap or sanitizer (described in statistical reporting number 8413.20.0000) (22) Hand pumps for liquids (other than those of subheading 8413.11 or 8413.19) of acrylonitrile butadiene styrene (ABS) plastics (described in statistical reporting number 8413.20.0000) (23) Indicator panels incorporating LEDs, designed for use in medical infusion equipment (described in statistical reporting number 8531.20.0040) (24) Data input devices each with display capabilities of a kind used for magnetic resonance imaging (“MRI”) equipment, computed tomography (“CT”) equipment, intraoperative X-ray (“IXR”) equipment or patient monitors (described in statistical reporting number 8537.10.9170) (25) Compound binocular optical microscopes (other than stereoscopic microscopes and microscopes for photomicrography, cinemicrography or microprojection), each with magnification of 40X or more but not exceeding 1,000X, weighing not more than 3 kg (described in statistical reporting number 9011.80.0000) (26) Compound optical microscopes (other than stereoscopic microscopes and microscopes for photomicrography, cinemicrography or microprojection), each with magnification of 40X or more but not exceeding 400X, weighing not more than 15 kg (described in statistical reporting number 9011.80.0000) “(iv) The U.S. Trade Representative determined to establish a process by which particular products classified in heading 9903.88.15 and provided for in U.S. notes 20(r) and (s) to this subchapter could be excluded from the additional duties imposed by heading 9903.88.15. See 84 Fed. Reg. 43304 (August 20, 2019), 84 Fed. Reg. 45821 (August 30, 2019), 84 Fed. Reg. 57144 (October 24, 2019) and 85 Fed. Reg. 3741 (January 22, 2020). Pursuant to the product exclusion process, the U.S. Trade Representative has determined that, as provided in heading 9903.88.66, the additional duties provided for in heading 9903.88.15 shall not apply to the following particular products, which are provided for in the following enumerated statistical reporting numbers: (1) 3401.19.0000 (2) 3926.90.9910 9 (3) 4818.90.0000 prior to July 1, 2020; 4818.90.0020 or 4818.90.0080 effective July 1, 2020 (4) 5210.11.4040 (5) 5210.11.6020 (6) 5504.10.0000 (7) 6210.10.5010 (8) 6210.10.5090 (9) 6307.90.7200 (10) Face shields of transparent plastics, whether or not assembled (described in statistical reporting number 3926.90.9950) (11) Bowls of molded plastics, with clips for retaining guide wires during surgical procedures (described in statistical reporting number 3926.90.9990 prior to July 1, 2020; described in statistical reporting number 3926.90.9985 effective July 1, 2020) (12) Coverings, of plastics, designed to fit over wound sites or casts thereby forming a protective seal for keeping the covered area dry and debris free while showering or bathing (described in statistical reporting number 3926.90.9990 prior to July 1, 2020; described in statistical reporting number 3926.90.9985 effective July 1, 2020) (13) Disposable graduated medicine dispensing cups of plastics (described in statistical reporting number 3926.90.9990 prior to July 1, 2020; described in statistical reporting number 3926.90.9985 effective July 1, 2020) (14) Single-use sterile drapes and covers of plastics, of a kind used to protect the sterile field in surgical operating rooms (described in statistical reporting number 3926.90.9990 prior to July 1, 2020; described in statistical reporting number 3926.90.9985 effective July 1, 2020) (15) Sterile decanters of polystyrene plastics, each of a kind used to transfer aseptic fluids or medication to and from sterile bags, vials or glass containers (described in statistical reporting number 3926.90.9990 prior to July 1, 2020; described in statistical reporting number 3926.90.9985 effective July 1, 2020) (16) Cold packs consisting of a single-use, instant, endothermic chemical reaction cold pack combined with a textile exterior lining (described in statistical reporting number 6307.90.9889 prior to July 1, 2020; described in statistical reporting number 6307.90.9891 effective July 1, 2020) (17) Hot packs of textile material, single-use (exothermic chemical reaction) (described in statistical reporting number 6307.90.9889 prior to July 1, 2020; described in statistical reporting number 6307.90.9891 effective July 1, 2020) (18) Laparotomy sponges of cotton (described in statistical reporting number 6307.90.9889 prior to July 1, 2020; described in statistical reporting number 6307.90.9891 effective July 1, 2020) (19) Single-use blood pressure cuff sleeves of textile materials (described in statistical reporting number 6307.90.9889 prior to July 1, 2020; described in statistical reporting number 6307.90.9891 effective July 1, 2020) (20) Single-use stethoscope covers (described in statistical reporting number 6307.90.9889 prior to July 1, 2020; described in statistical reporting number 6307.90.9891 effective July 1, 2020) 10 (21) Woven gauze sponges of cotton in square or rectangular sizes (described in statistical reporting number 6307.90.9889 prior to July 1, 2020; described in statistical reporting number 6307.90.9891 effective July 1, 2020) (22) Protective Articles (described in statistical reporting number 9004.90.0000 prior to January 1, 2021; described in statistical reporting number 9004.90.0010 or 9004.90.0090 effective January 1, 2021)”. 3. by amending the last sentence of the first paragraph of U.S. note 20(a) to subchapter III of chapter 99 by: a. by deleting “or (13)” and by inserting “(13)” in lieu thereof; and b. by inserting “; or (14) heading 9903.88.66 and U.S. note 20(sss)(i) to subchapter III of chapter 99” after the phrase “U.S. note 20(ooo) to subchapter III of chapter 99”, where it appears at the end of the sentence. 4. by amending U.S. note 20(b) to subchapter III of chapter 99 by: a. by deleting “or (13)” and by inserting “(13)” in lieu thereof; and b. by inserting “; or (14) heading 9903.88.66 and U.S. note 20(sss)(i) to subchapter III of chapter 99” after the phrase “U.S. note 20(ooo) to subchapter III of chapter 99”, where it appears at the end of the sentence. 5. by amending the last sentence of the first paragraph of U.S. note 20(c) to subchapter III of chapter 99 by: a. by deleting “or (7)” and by inserting “(7)” in lieu thereof; and b. by inserting “; or (8) heading 9903.88.66 and U.S. note 20(sss)(ii) to subchapter III of chapter 99” after the phrase “U.S. note 20(ppp) to subchapter III of chapter 99”, where it appears at the end of the sentence. 6. by amending U.S. note 20(d) to subchapter III of chapter 99 by: a. by deleting “or (7)” and by inserting “(7)” in lieu thereof; and b. by inserting “; or (8) heading 9903.88.66 and U.S. note 20(sss)(ii) to subchapter III of chapter 99” after the phrase “U.S. note 20(ppp) to subchapter III of chapter 99”, where it appears at the end of the sentence. 7. by amending the last sentence of the first paragraph of U.S. note 20(e) to subchapter III of chapter 99 by: a. by deleting “or (16)” and by inserting “(16)” in lieu thereof; and 11 b. by inserting “; or (17) heading 9903.88.66 and U.S. note 20(sss)(iii) to subchapter III of chapter 99” after the phrase “U.S. note 20(qqq) to subchapter III of chapter 99”, where it appears at the end of the sentence. 8. by amending U.S. note 20(f) to subchapter III of chapter 99 by: a. by deleting “or (16)” and by inserting “(16)” in lieu thereof; and b. by inserting “; or (17) heading 9903.88.66 and U.S. note 20(sss)(iii) to subchapter III of chapter 99” after the phrase “U.S. note 20(qqq) to subchapter III of chapter 99”, where it appears at the end of the sentence. 9. by amending the last sentence of the first paragraph of U.S. note 20(r) to subchapter III of chapter 99: a. by deleting “or (10)” and by inserting “(10)” in lieu thereof; and b. by inserting “, or (11) heading 9903.88.66 and U.S. note 20(sss)(iv) to subchapter III of chapter 99” after “U.S. note 20(rrr) to subchapter III of chapter 99”. 10. by amending the article description of heading 9903.88.01: a. by deleting “9903.88.60 or”; b. by inserting in lieu thereof “9903.88.60,”; and c. by inserting “or 9903.88.66,” after “9903.88.62,”. 11. by amending the article description of heading 9903.88.02: a. by deleting “9903.88.61 or”; b. by inserting in lieu thereof “9903.88.61,”; and c. by inserting “or 9903.88.66,” after “9903.88.63,”. 12. by amending the article description of heading 9903.88.03: a. by deleting “9903.88.56 or”; b. by inserting in lieu thereof “9903.88.56,”; and c. by inserting “or 9903.88.66,” after “9903.88.64,”. 13. by amending the article description of heading 9903.88.04: 12 a. by deleting “9903.88.56 or”; b. by inserting in lieu thereof “9903.88.56,” ; and c. by inserting “or 9903.88.66” after “9903.88.64”. 14. by amending the article description of heading 9903.88.15: a. by deleting “9903.88.57 or” and by inserting “9903.88.57,” in lieu thereof; and b. by inserting “or 9903.88.66,” after “9903.88.65,”. 13